🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.

“The shining star of our family has faded away for us in this life,” his relatives stated. “After a prolonged and brave battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his fans around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and partnerships with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album reached the fourth spot on the R&B charts, earned platinum status soon after, and received multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the limelight. The record debuted at No. 1 on both the R&B charts and the Billboard 200. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The personal depiction featured the singer, famously stripped down to his waist, performing directly into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with another No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Again, in his own enigmatic way, D’Angelo made only a few public outings in the following years.

The musician was scheduled as a top act for the 2025 music event, but his performance was called off, citing an “unexpected health issue.”

Even though details are sparse about D’Angelo’s well-being in the months before his death, he had reportedly been in the hospital for an extended period and in palliative care for a fortnight.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent forms of the disease, on a brilliant talent whose existence was cut short.

“We are saddened that he can only provide dear memories with his family, but we are eternally grateful for the legacy of extraordinarily moving music he has left us,” his family said.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic malignancy affects the pancreas, a small organ that generates the hormone insulin and is vital in digestion, among other functions. The size and location of the pancreas in the human system make it more challenging to detect malignancy.

Even though this cancer makes up only about 3% of malignancy cases annually in the U.S., it is responsible for 7% of cancer deaths.

Nearly 70,000 people will be diagnosed with this condition and roughly 52,000 will die of the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and ineffective treatment options, and a smaller window to make a meaningful impact on the lives of people,” said a medical oncologist.

Because pancreatic cancer rarely causes early symptoms, it’s frequently diagnosed only after the condition is advanced. Even when a patient has indicators they are often nonspecific and may be confused with a several common illnesses.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, apart from listening to your body and consulting your doctor if there are new or unusual symptoms,” said a medical director.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• brownish urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is most common in adults in the 65 to 75 range. However, numerous malignancies, including pancreatic cancer, have become more common among younger people.

“This disease diagnosed before the age of 50 is considered rare, yet concerningly, doctors are beginning to see a growing number of younger patients suffering from this condition,” commented a expert.

Genetic Background Impacts Cancer Risk

In the absence of effective screening tools for pancreatic cancer, experts emphasized the importance of knowing your family’s health background. Some risk factors, such as smoking and obesity also play a role in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s chance of this condition is assessing individual susceptibility. Individuals should examine their family history, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or overweight that may increase their susceptibility,” advised a medical professional.

Hereditary risk factors are associated with as much as 10% of all pancreatic cancer cases. If a relative in your family has had pancreatic cancer, you may want to consider DNA analysis.

“For people with a family history of this condition or those having high risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The most effective step you can take to reduce your susceptibility of this disease is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy drinking is linked to pancreatitis, a risk factor for this malignancy, so limiting or avoiding alcohol may help lower your chance.

Controlling your weight or losing weight may also help decrease your susceptibility. People with excess weight are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in those with diabetes, and reducing weight can also lower the risk of adult-onset diabetes.

In spite of this disease’s grim outlook, there is still hope.

“We are doing better with therapies and more recent combination chemotherapy. There are developing targeted therapies that are already making an impact,” remarked a expert.

For many people, however, awareness about this uncommon but {dev